Regeneron defeated in GM mouse patent row

11-08-2015

Regeneron defeated in GM mouse patent row

CreativeNature R.Zwerver / Shutterstock.com

A US court has ruled that biotechnology company Regeneron engaged in “inequitable conduct” after finding that it withheld information from a patent application for a genetically modified mouse.


Regeneron; Merus; US District Court for the Southern District of New York; patent; genetically modified mouse

LSIPR